Rapid Communication
Copyright ©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Mar 14, 2008; 14(10): 1582-1587
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1582
Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma
Chong-Zhi Zhou, Guo-Qiang Qiu, Jun-Wei Fan, Xiao-Liang Wang, Hua-Mei Tang, Li Huang, Yu-Hao Sun, Zhi-Hai Peng
Chong-Zhi Zhou, Guo-Qiang Qiu, Jun-Wei Fan, Xiao-Liang Wang, Li Huang, Yu-Hao Sun, Zhi-Hai Peng, Department of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, China
Hua-Mei Tang, Department of Pathology, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, China
Author contributions: Zhou CZ, Qiu GQ, Peng Z designed research; Zhou CZ, Qiu GQ, Fan JW, Wang XL, Huang L, Sun YH performed research; Tang HM contributed pathologic confirm; Zhou CZ, Qiu GQ analyzed data; and Zhou CH wrote the paper.
Correspondence to: Dr. Zhi-Hai Peng, Department of General Surgery, Shanghai Jiaotong University affiliated First People's Hospital, 85 Wujin Road, Shanghai 200080, China. pengpzh@hotmail.com
Telephone: +86-21-63240090-3102
Fax: +86-21-63241377
Received: November 1, 2007
Revised: January 2, 2008
Published online: March 14, 2008
Abstract

AIM: To explore precise deleted regions and screen the candidate tumor suppressor genes related to sporadic colorectal carcinoma.

METHODS: Six markers on 1q31.1-32.1 were chosen. These polymorphic microsatellite markers in 83 colorectal cancer patients tumor and normal DNA were analyzed via PCR. PCR products were electrophoresed on an ABI 377 DNA sequencer. Genescan 3.1 and Genotype 2.1 software were used for Loss of heterozygosity (LOH) scanning and analysis. Comparison between LOH frequency and clinicopathological factors was performed by χ2 test.

RESULTS: 1q31.1-32.1 exhibited higher LOH frequency in colorectal carcinoma. The average LOH frequency of 1q31.1-32.1 was 23.0%, with the highest frequency of 36.7% (18/49) at D1S2622, and the lowest of 16.4% (11/67) at D1S412, respectively. A minimal region of frequent deletion was located within a 2 cM genomic segment at D1S413-D1S2622 (1q31.3-32.1). There was no significant association between LOH of each marker on 1q31.1-32.1 and the clinicopathological data (patient sex, age, tumor size, growth pattern or Dukes stage), which indicated that on 1q31.1-32.1, LOH was a common phenomenon in all kinds of sporadic colorectal carcinoma.

CONCLUSION: Through our refined deletion mapping, the critical and precise deleted region was located within 2 cM chromosomal segment encompassing 2 loci (D1S413, D1S2622). No significant association was found between LOH and clinicopathologic features in 1q31.1-32.1.

Keywords: Sporadic colorectal carcinoma; Loss of heterozygosity; Tumor suppressor genes; 1q31.1-32.1